[Survival analysis of patients with intrahepatic cholangiocarcinoma treated with adjuvant chemotherapy after radical resection based on CoxPH model and deep learning algorithm].
Jing Chen(Zhejiang Institute of Special Equipment Inspection), Z W Quan(XinHua Hospital), Zhaohui Tang(XinHua Hospital), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Xiaoqing Yu(Max Planck Institute for Polymer Research), Yicheng Qiu(Shanghai Third People's Hospital), C Chen(First Affiliated Hospital of Xi'an Jiaotong University), Zhangjun Cheng(Zhongda Hospital Southeast University), Wu H(Tongji University), Yujun He(University of Colorado Denver), Yi Tang(XinHua Hospital), X H Mao(Hunan Provincial People's Hospital), Zhimin Geng(Children's Hospital of Zhejiang University), J D Li(GlaxoSmithKline (China)), Wenlong Zhai(Zhengzhou University)
Cited by 0
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
|EBioMedicine|2016|345
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
|Proceedings of the National Academy of Sciences|2018|324
Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts
|Cell stem cell|2010|112